1. Home
  2. BMRA vs PRPO Comparison

BMRA vs PRPO Comparison

Compare BMRA & PRPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biomerica Inc.

BMRA

Biomerica Inc.

N/A

Current Price

$2.36

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Logo Precipio Inc.

PRPO

Precipio Inc.

N/A

Current Price

$26.44

Market Cap

42.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
BMRA
PRPO
Founded
1971
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
42.0M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
BMRA
PRPO
Price
$2.36
$26.44
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
185.7K
133.3K
Earning Date
04-13-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.81
92.15
EPS
N/A
N/A
Revenue
$4,453,000.00
$24,049,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
29.77
52 Week Low
$1.45
$16.01
52 Week High
$3.21
$33.63

Technical Indicators

Market Signals
Indicator
BMRA
PRPO
Relative Strength Index (RSI) 67.98 52.63
Support Level $2.05 $25.46
Resistance Level $2.58 $29.20
Average True Range (ATR) 0.21 1.90
MACD 0.02 -0.28
Stochastic Oscillator 84.72 33.13

Price Performance

Historical Comparison
BMRA
PRPO

About BMRA Biomerica Inc.

Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

Share on Social Networks: